SRLS Financial Facts

Reorganization items: 0
Research and development expense: 412.23K
See Full Income Statement

Total current assets: 37.1M
Total assets: 47.19M
See Full Balance Sheet

SeraCare Life Sciences (SRLS) Earnings

  |   Expand Research on SRLS
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -66.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/10/12 Q112 $0.07$0.04 +$0.03$11.4M$11.05M N/A Details
11/17/11 Q411 -$0.04$0.02 -$0.06$10.99M$10.95M N/A Details
7/26/11 Q311 $0.03$0.07 -$0.04$11M$11.82M N/A Details
5/12/11 Q111 $0.07$0.06 +$0.01$11M$11.21M N/A Details
2/11/11 Q111 $0.08$0.08 $0.00$10.5M$11.83M N/A Details
12/1/10 Q410 $0.11$0.08 +$0.03N/AN/A N/A Details